VAN NAARDEN JACOB (Chief Business Officer) sold 18.4% of their position (3.08K shares) of LOXO ONCOLOGY, INC. on the open market
Open‑market sale worth $565.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+1.54K
Price / share
$3.65
Trade value
$5.62K
% of position
Common Stock
Shares
−300.00
Price / share
$185.34
Trade value
$55.60K
% of position
Common Stock
Shares
−200.00
Price / share
$186.19
Trade value
$37.24K
% of position
Common Stock
Shares
−641.00
Price / share
$187.37
Trade value
$120.11K
% of position
Common Stock
Shares
−200.00
Price / share
$188.04
Trade value
$37.61K
% of position
Common Stock
Shares
−100.00
Price / share
$189.12
Trade value
$18.91K
% of position
Common Stock
Shares
−100.00
Price / share
$191.64
Trade value
$19.16K
% of position
Common Stock
Shares
+1.54K
Price / share
$3.65
Trade value
$5.62K
% of position
Common Stock
Shares
−680.00
Price / share
$178.39
Trade value
$121.31K
% of position
Common Stock
Shares
−361.00
Price / share
$179.50
Trade value
$64.80K
% of position
Common Stock
Shares
−300.00
Price / share
$180.95
Trade value
$54.28K
% of position
Common Stock
Shares
−100.00
Price / share
$181.96
Trade value
$18.20K
% of position
Common Stock
Shares
−100.00
Price / share
$183.19
Trade value
$18.32K
% of position
Net shares
+0.00
Net value
-$554.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/9/2018 | M · Option Exercise | +1.54K | $3.65 | $5.62K | 11.2% | 13.70K | 15.24K |
| Common Stock Direct | 7/9/2018 | S · Sale | −300.00 | $185.34 | $55.60K | 2.0% | 15.24K | 14.94K |
| Common Stock Direct | 7/9/2018 | S · Sale | −200.00 | $186.19 | $37.24K | 1.3% | 14.94K | 14.74K |
| Common Stock Direct | 7/9/2018 | S · Sale | −641.00 | $187.37 | $120.11K | 4.3% | 14.74K | 14.10K |
| Common Stock Direct | 7/9/2018 | S · Sale | −200.00 | $188.04 | $37.61K | 1.4% | 14.10K | 13.90K |
| Common Stock Direct | 7/9/2018 | S · Sale | −100.00 | $189.12 | $18.91K | 0.7% | 13.90K | 13.80K |
| Common Stock Direct | 7/9/2018 | S · Sale | −100.00 | $191.64 | $19.16K | 0.7% | 13.80K | 13.70K |
| Common Stock Direct | 7/10/2018 | M · Option Exercise | +1.54K | $3.65 | $5.62K | 11.2% | 13.70K | 15.24K |
| Common Stock Direct | 7/10/2018 | S · Sale | −680.00 | $178.39 | $121.31K | 4.5% | 15.24K | 14.56K |
| Common Stock Direct | 7/10/2018 | S · Sale | −361.00 | $179.50 | $64.80K | 2.5% | 14.56K | 14.20K |
| Common Stock Direct | 7/10/2018 | S · Sale | −300.00 | $180.95 | $54.28K | 2.1% | 14.20K | 13.90K |
| Common Stock Direct | 7/10/2018 | S · Sale | −100.00 | $181.96 | $18.20K | 0.7% | 13.90K | 13.80K |
| Common Stock Direct | 7/10/2018 | S · Sale | −100.00 | $183.19 | $18.32K | 0.7% | 13.80K | 13.70K |
| Total | +0.00 | -$554.30K | ||||||
Employee Stock Option (right to buy)
Common Stock
1.54K shares
Shares
−1.54K
Strike price
3.648
Held after
79.81K
Exercisable
—
Employee Stock Option (right to buy)
Common Stock
1.54K shares
Shares
−1.54K
Strike price
3.648
Held after
78.27K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock1.54K shares | 7/9/2018 | M · Option Exercise | −1.54K | 3.648 | — | 79.81K |
| Employee Stock Option (right to buy) Direct | Common Stock1.54K shares | 7/10/2018 | M · Option Exercise | −1.54K | 3.648 | — | 78.27K |